0
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Comment on Tsioti et al’s “Systemic Lipopolysaccharide Exposure Exacerbates Choroidal Neovascularization in Mice”

, PhD & , PhD
Received 29 Jun 2024, Accepted 02 Jul 2024, Published online: 23 Jul 2024

References

  • Tsioti I, Steiner BL, Escher P, Zinkernagel MS, Benz PM, Kokona D. Systemic lipopolysaccharide exposure exacerbates choroidal neovascularization in mice. Ocul Immunol Inflamm. 2024;32(1):19–30. doi:10.1080/09273948.2022.2147547.
  • Schwarzer P, Kokona D, Ebneter A, Zinkernagel MS. Effect of inhibition of colony-stimulating factor 1 receptor on choroidal neovascularization in mice. Am J Pathol. 2020;190(2):412–425. doi:10.1016/j.ajpath.2019.10.011.
  • Combrinck MI, Perry VH, Cunningham C. Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease. Neuroscience. 2002;112(1):7–11. doi:10.1016/S0306-4522(02)00030-1.
  • Noailles A, Maneu V, Campello L, Lax P, Cuenca N. Systemic inflammation induced by lipopolysaccharide aggravates inherited retinal dystrophy. Cell Death Dis. 2018;9(3):350. doi:10.1038/s41419-018-0355-x.
  • Matsumura N, Kamei M, Tsujikawa M, Suzuki M, Xie P, Nishida K, et al. Low-dose lipopolysaccharide pretreatment suppresses choroidal neovascularization via IL-10 induction. PLOS ONE. 2012;7(7):e39890. doi:10.1371/journal.pone.0039890.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.